Rheumatologist MD PhD | 2019-2020 Chair of @EMEUNET | 2023-2025 Leader young @Official_ASAS | Interests: SpA/RA diagnosis/outcomes, epidemiology, biostatistics
Joined June 2017
- Tweets 1,772
- Following 675
- Followers 1,192
- Likes 2,728
42 Photos and videos
Alexandre Sepriano retweeted
📣 Coming soon…
ARP Rheumatology x @SPReumatologia are launching a new initiative to train the next generation of scientific reviewers
If you're an SPR member interested in peer review & publishing — stay tuned.
🔜 Announcement very soon
#Rheumatology #PeerReview #SPR #ARP
2
3
279
Alexandre Sepriano retweeted
We are delighted to welcome Prof. @AlexSepriano as Methodological & Statistical Reviewer
A former Editor-in-Chief (2021–2025 and expert in epidemiology, biostatistics, and imaging outcomes, he strengthens our commitment to research excellence
Welcome back! 👏📊
1
5
138
Alexandre Sepriano retweeted
🧬 Rheumatoid nodules can be refractory—or even worsen—despite good joint control in RA.
📉 New case evidence shows cutaneous & pulmonary nodule regression with upadacitinib
➡️ Suggesting JAK inhibition effects beyond synovitis
🔗arprheumatology.com/section.…
3
4
200
Alexandre Sepriano retweeted
29 Dec 2025
🌟 Thank you to the Top Reviewers of ARP Rheumatology 2025
Your expertise and dedication to rigorous peer review help advance excellence in rheumatology research 🔬📘
Thank you for your invaluable contribution to advancing excellence in rheumatology research 💙
2
3
102
Alexandre Sepriano retweeted
23 Dec 2025
Season’s Greetings from ARP Rheumatology ✨
Grateful to our amazing community for another year of collaboration and science.
Wishing you happy holidays and a healthy New Year! 📷 🌟
1
5
135
Last month, Sophia Rein was awarded a grant during the 2025 ADIA Lab symposium.
‘Causal AI for the Generation of Real-World Evidence from Healthcare Data’ will support software development for Causal AI (combining the g-formula with deep learning). Congrats, Sophia!
ALT Sophia Rein ADIA 2025 presentation
1
10
981
Alexandre Sepriano retweeted
17 Nov 2025
Difficult-to-manage #PsoriaticArthritis
Include drivers such as
▶️Inflammation
▶️Comorbidities
▶️Psychosocial or other factors
Treatment-refractory PsA
▶️Persistent disease activity
▶️Objective evidence of active inflammation
👉🏽ard.eular.org/article/S0003-…
via @eular_ARD @eular_org
5
5
382
Alexandre Sepriano retweeted
9 Nov 2025
🩺 Clinical Case Challenge
A 62-year-old woman presents with:
🫗 Bilateral parotid swelling
👁️ Dry eyes/mouth
🧠 Fatigue & weight loss
🧪 Labs: cytopenia, ↓complement, ↑ACE, ↑β₂-microglobulin
📸 Imaging: enlarged parotids lymphadenopathy
⭐️ What’s the most likely diagnosis?
0%
Sjögren’s
0%
IgG4-related disease
75%
New/relapse of lymphoma
25%
Sarcoidosis
4 votes • Final results
1
3
3
118
Alexandre Sepriano retweeted
30 Sep 2025
🚨 New editorial in ARP Rheumatology: 5 years at a glance
📖 309 articles
🌍 ~50% international
⏱️ 36% faster publication
🔗 20 Reuma.pt studies
🌐 Expanded digital & SM presence
Read 👉 arprheumatology.com/section.…
2
3
222
Alexandre Sepriano retweeted
22 Sep 2025
📰 Don’t miss this month’s Editor’s Choice selected by Prof @TaniaLSantiago ✨
📌 PORTRESS: first nationwide registry for Sjögren’s in Portugal 🇵🇹
📌 Cervical CPPD
📌 ASAS definition of D2M & TR axSpA: first real-world insights
🔗 Read FREE: arprheumatology.com
3
6
269
Alexandre Sepriano retweeted
10 Sep 2025
📢Online First
Pemphigus foliaceus case with atypical hypocomplementemic urticarial vasculitis
Findings: hypocomplementemia thrombocytopenia hepatomegaly → B-cell lymphoproliferative disorder
⚠️ Vasculitic lesions may signal malignancy
🔗 arprheumatology.com/article_…
3
4
130
Alexandre Sepriano retweeted
4 Jul 2025
✨The 2024 IF for ARP Rheumatology is 1.4!
📈 Our first total IF under the new name keeps the growth from 1.375 in 2022, securing a solid Q3 position.
🙏 Thank you to our authors, reviewers, Associate Editors & community for making this possible — and here’s to more growth ahead!
4
5
329
Alexandre Sepriano retweeted
3 May 2025
It’s World AS Day!
How are you spreading awareness about axial spondyloarthritis today? Share your activities in the comments.
Thank you to everyone raising awareness and driving change today!
#WorldASDay2025 #LaceUpForAxSpA #EverydayChallenges
1
20
34
4,026
Alexandre Sepriano retweeted
17 Mar 2025
New from the Slide Library: ASAS publication from @AlexSepriano et al
Higher ASDAS was longitudinally associated with higher spinal radiographic progression in patients with r-axSpA independently of treatment with TNFi.
👉 pubmed.ncbi.nlm.nih.gov/3311…
8
10
1,180
Alexandre Sepriano retweeted
7 Feb 2025
📣 MORE NEWS FROM ASAS
Congratulations to Prof. Raj Sengupta on his election to the ASAS Executive Committee!
We are also pleased to announce Prof. Pedro Machado’s new role as Executive Secretary of the ASAS Executive Committee.
#asas2025 #asa30yrs
2
4
27
2,196
Alexandre Sepriano retweeted
5 Feb 2025
Mark your calendars for an essential session at the ASAS Core Course! Dr. Baraliakos will present his viewpoint on 'Rethinking Structural Progression in axSpA: A Balanced Approach.'
#SpA #Rheumatology #ASASCoreCourse #StructuralProgression"
2
12
660
Alexandre Sepriano retweeted
7 Feb 2024
News from the ASAS annual meeting held in Barcelona:
Denis Poddubnyy and Wilson Bautista-Molano were elected as incoming ASAS Executive Committee members
1
2
27
1,609
Alexandre Sepriano retweeted
29 Jan 2025
📣 The Core Course on Spondyloarthritis has been granted 8 European
CME credits.
👉 asas-group.org/the-2025-asas…
#SpA #Rheumatology #ASASCoreCourse
2
5
600